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Taggart, Balacumaraswami, Pigott, Abu-Omar,
Choudhary (left to right)doi:10.1016/j.jtcvs.2004.11.033Background: Intraoperative graft patency assessment during coronary artery bypass
grafting enables detection and immediate correction of graft failure. Currently
transit-time flowmetry is used to assess graft patency on the basis of mean graft flow
and derived values, such as the pulsatility index. Intraoperative fluorescence imag-
ing, based on the fluorescence of indocyanine green dye, provides direct visual
images to confirm graft patency.
Methods: We performed a prospective observational study to assess intraoperative
graft patency in patients undergoing coronary artery bypass grafting, by using an
intraoperative fluorescence imaging system (SPY) and transit-time flowmetry (BF
2004). Poor flow with the intraoperative fluorescence imaging system was defined
if there was an absence of fluorescence or if it did not appear within 15 seconds in
the graft. A persistent mean graft flow value less than 5 mL/min and a pulsatility
index greater than 5 with transit-time flowmetry were considered unacceptable and
prompted graft revision.
Results: We assessed the intraoperative patency of 266 grafts in 100 coronary artery
bypass grafting patients. Intraoperative fluorescence imaging and transit-time flow-
metry confirmed adequate flow in 241 (91%) grafts in 75 patients (75%). Transient
poor flow was detected with both intraoperative fluorescence imaging and transit-
time flowmetry in 7 (2.6%) grafts in 7 (7%) patients. This subsequently proved to
be adequate on repeat testing and hence did not necessitate graft revision. Both
intraoperative fluorescence imaging and transit-time flowmetry confirmed persistent
poor flow in 8 (3%) grafts in 8 (8%) patients that necessitated graft revision.
However, in a further 10 (3.8%) grafts in 10 (10%) patients, transit-time flowmetry
indicated persistently poor flows on the basis of mean graft flow and pulsatility
index values, whereas the intraoperative fluorescence imaging system demonstrated
satisfactory flow. These grafts were not revised.
Conclusions: In most patients, both intraoperative fluorescence imaging and transit-
time flowmetry are useful to confirm intraoperative graft patency. However, in a
small proportion of patients (10%), graft patency assessment with transit-time
flowmetry alone might prompt unnecessary graft revision.
Intraoperative graft failure is a potentially avoidable major cause of cardiacmorbidity and mortality and occurs in up to 3% of grafts (8% of patients) aftercoronary artery bypass grafting (CABG).1 It is the most common cause of
perioperative myocardial infarction and occurs in up to 9% of patients before
hospital discharge.2 CABG ideally mandates the use of objective technology to
evaluate graft patency. In addition, the increase in the use of arterial grafts3 and
off-pump CABG (OPCABG)4 has further emphasized the need to confirm intraop-
erative graft patency.
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CSPThe most common method of intraoperative CABG pa-
tency assessment is based on flow measurements obtained
with transit-time flowmetry (TTFM). TTFM provides a
mean graft flow (MGF), a flow waveform, and derived
values such as the pulsatility index (PI). Although higher
MGF values (40 mL/min) with a predominant diastolic
profile are easy to interpret as adequate graft patency, in
situations with low MGF, graft patency interpretation de-
pends on derived values, which can introduce uncertainty.
This allows the potential for erroneous interpretation of
graft failure. D’Ancona and colleagues1 reported the neces-
sity to revise 3% of grafts on the basis of TTFM and
emphasized the crucial feature of flow value interpretation
as an index of graft patency.
We recently described the use of an intraoperative fluo-
rescence imaging (IFI) system (SPY; Novadaq Technolo-
gies Inc, Mississauga, Ontario, Canada), which provides
direct visual images to assess graft patency.5 Using this
system, we prospectively studied 200 patients undergoing
mainly off-pump total arterial grafting and demonstrated a
natural graft failure incidence of 1.5% (8/533 grafts). This
occurred in 4% (8/200) of patients and prompted
revision.6We have now used the information simultaneously
provided by IFI and TTFM to assess graft patency in pa-
tients undergoing CABG with the same strategy.
Materials and Methods
Study Approval
This study was approved by the Oxfordshire research ethics com-
mittee, and informed consent was obtained from all patients in-
cluded in the study.
Patients
All patients undergoing CABG performed by a single surgeon
(D.P.T.) between April 2003 and January 2004 were included in
the study unless, for technical reasons, the equipment was not
available. Intraoperative graft patency data were prospectively
recorded in 100 patients, simultaneously using an IFI system
(SPY) and TTFM (BF 2004; Medistim AS, Oslo, Norway) after
construction of the grafts and before chest closure.
Surgical Technique
All patients underwent CABG via a median sternotomy. Both
internal thoracic arteries (ITAs) were harvested as skeletonized
conduits. The skeletonized ITA was bathed in a swab containing
topical papaverine. The radial artery was harvested and stored in
heparinized blood containing phenoxybenzamine in the earlier
patients7 and additional verapamil in the later patients before the
anastomosis was performed. The long saphenous vein was har-
vested with a minimally invasive technique.
Our strategy for construction of anastomoses and the surgical
technique for performing OPCABG and on-pump CABG
(ONCABG) have been previously described.6 Some of the later
patients in the ONCABG group with poor ventricular function had
316 The Journal of Thoracic and Cardiovascular Surgery ● AuguCABG with cardiopulmonary bypass, but on a beating heart with-
out the use of the aortic crossclamp to avoid any ischemic period.
Data Collection
Intraoperative fluorescence imaging. IFI is a technique based
on the fluorescence of indocyanine green (ICG). We have de-
scribed this technique previously.5 In brief, ICG rapidly binds to
plasma proteins when injected intravenously and fluoresces (emits
light at 830 nm) when illuminated with a monochromatic laser
light source at 806 nm. The fluorescence is captured on a charge-
coupled device video camera. The low-intensity laser, with a total
output of 2.7 W and a 1-mm depth of penetration over an area of
7.5  7.5 cm, at a distance of 30 cm above the heart, has an
excellent safety profile for both the patient and the operating room
staff. The system has CE approval in Europe; this allows patient
use in the European community. ICG has an excellent safety
profile, with a reported 1:40,000 incidence of allergic reaction,
especially in patients allergic to iodine.8 The risk is strongly dose
dependent and is greatest with doses more than 0.5 mg/kg body
weight.
The sterile draped camera head, guided by a range-detector
diode, was positioned at 30 cm above the heart. On completion of
the distal coronary anastomosis, 1 mL (0.03 mg/kg) of ICG dye
was injected into the oxygenator in ONCABG or was injected
through the central venous line and flushed through with 10 mL of
normal saline in OPCABG. Screening was started at the time of
injection, and the grafts were imaged as the fluorescent dye passed
through them. Images were then recorded on the computer hard
drive. The procedure took approximately 3 minutes per graft.
Skeletonized conduits provided better visualization than pedicled
ones. The appearance of fluorescent images as the dye passed
through the bypass grafts confirmed graft patency.
Transit-time flowmetry. The technique for use of TTFM has
been described by D’Ancona and colleagues.1 In brief, the TTFM
QuickFit flow probes (Medistim AS, Norway) were sterilized with
Tristel sterilizing solution (The Tristel Company, Snailwell,
United Kingdom) and prepared for intraoperative use. Patient data
were entered into the transit-time flowmeter (BF 2004), and the
integrated chart recorder on the monitor displayed the flow wave-
form and its analysis and simultaneously recorded the electrocar-
diogram and systemic arterial pressure. The ultrasound couplant
(gel) was applied to the flow probe lumen before it was positioned
on the graft such that the graft occupied at least 75% of the flow
probe lumen. TTFM provides a flow waveform profile and MGF
values. MGF values more than 40 mL/min indicate satisfactory
flow, and values less than 5 mL/min are considered unsatisfactory
and prompt revision.9 Certain derived values, such as PI and
diastolic flow index, are also displayed. PI is an absolute number
(defined as the difference between maximum and minimum flow
divided by the mean flow) that indicates the resistance to graft
flow, and a value more than 5 is considered unsatisfactory.10 A
diastolic flow index value more than 50% indicates a predomi-
nantly diastolic graft flow profile and is recognized as normal, akin
to native coronary artery blood flow.11
Definition of Graft Flow
The graft flow was assessed on the basis of simultaneous IFI
images and TTFM flow values recorded with the heart in the same
st 2005
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Pposition and with the same mean arterial blood pressure (MAP).
Using IFI as the gold standard, we defined flow on the basis of IFI
and TTFM as good or poor.
For IFI, good flow was defined as the appearance of fluores-
cence in the graft within 15 seconds, and poor flow was defined if
there was an absence of fluorescence or if it did not appear within
15 seconds. For TTFM, good flow was defined as an MGF value
greater than 5 mL/min with a PI value less than 5, and poor flow
was defined as an MGF less than 5 mL/min or a PI value greater
than 5.
On the basis of IFI and TTFM, we differentiated 4 categories
(Table 1):
1. Category GG: good flow with IFI and good flow with
TTFM
2. Category GP: good flow with IFI but poor flow with TTFM
3. Category PG: poor flow with IFI but good flow with TTFM
4. Category PP: poor flow with IFI and poor flow with TTFM
In cases in which poor flow values were initially documented
with either IFI or TTFM, graft flow was subsequently reassessed
after MAP increased to 80 mm Hg or more and 10 to 20 minutes
later while other grafts were completed. We revised grafts for
which there was persistent poor flow with both techniques (PPp)
despite adequate systemic MAP and did not revise those for which
flow had improved. This latter category was defined therefore as
transient poor flow (PPt).
Statistical Analysis
Results for categorical variables are expressed as number (percent-
age of total). Continuous variables are presented as mean  SD.
The 2 test was used for comparison of categorical variables. The
continuous variables were compared by using the Student t test.
Nonparametric data were compared by using the Mann-Whitney U
test.
Results
We obtained intraoperative graft flow values and images in
266 grafts performed in 100 patients. The mean number of
distal anastomoses was 2.7 per patient. Of these patients, 80
(80%) underwent OPCABG, and 20 (20%) underwent
ONCABG. The ONCABG group included 3 patients with
TABLE 1. Configuration of conduits used to perform distal
anastomosis in all patients (266 grafts)
Variable LAD OM PDA RCA IM D1 LVBR
LITA (n  98) 44 48 — — 3 3 —
RITA (n  50) 49 — — — — 1 —
RA (n  48) 2 7 20 3 6 10 —
SVG (n  70) 4 21 24 11 1 7 2
LITA, Left internal thoracic artery; RITA, right internal thoracic artery; RA,
radial artery; SVG, saphenous vein graft; LAD, left anterior descending
coronary artery; OM, obtuse marginal coronary artery; PDA, posterior
descending branch of the right coronary artery; RCA, right coronary artery;
IM, intermediate artery; D1, first diagonal branch of the left anterior
descending coronary artery; LVBR, left ventricular branch of the right
coronary artery.simultaneous aortic valve replacement.
The Journal of ThoraciIn patients with triple-vessel disease, the mean number of
grafts for the OPCABG and ONCABG groups was similar
(OPCABG, 3.2  0.4; ONCABG, 3.4  0.6). Overall, 57
(57%) patients had total arterial grafting; of these, compos-
ite arterial grafting was performed in 33 (33%) patients.
Excluding those with single-vessel disease, bilateral ITA
conduits were used in 49 (49%) patients. The configuration
of conduits used to perform distal coronary anastomoses is
detailed in Table 1.
On the basis of information obtained from the IFI and
TTFM techniques, we assessed intraoperative graft patency
in 266 grafts and identified 4 categories based on graft
patency interpretation (Table 2). Good flow with both IFI
and TTFM (category GG) was seen in 241 (91%) grafts in
75 (75%) patients. In 10 (3.8%) grafts in 10 (10%) patients,
good flow was confirmed by IFI, but persistent poor flow
values were recorded with TTFM (category GP), and these
grafts were not revised (Table 3). No grafts demonstrated
poor IFI flow but good TTFM flow (category PG).
Poor flow with both IFI and TTFM (category PP) was
initially observed in 15 (5.6%) grafts in 15 (15%) patients
and was subsequently subclassified as transient (category
PPt) or persistent (category PPp). Of the 15 grafts initially
classified as PP, 7 (2.6%) grafts in 7 (7%) patients subse-
quently demonstrated good flow with IFI and TTFM and
were therefore classified as PPt and did not undergo graft
revision (Table 4). In these cases, the MGF increased sig-
nificantly, from the initial measurement of 4.1  4.3 mL/
min to 16.3  10.3 mL/min (P  .02), and this was
accompanied by a significant decrease in PI from 9.6  3.7
to 3.1  0.9 (P  .001).
However, of the 15 grafts initially classified as PP, per-
sistent poor flow on repeat assessment was seen with both
TABLE 2. Categories based on graft patency assessment in
266 grafts (100 patients) with intraoperative fluorescence
imaging (IFI) and transit-time flowmetry (TTFM)
Flow variable Good TTFM flow Poor TTFM flow
Good IFI flow GG GP
No. grafts 241 (91%) 10 (3.8%)
No. patients 75 (75%) 10 (10%)
Poor IFI flow PG PPt
No. grafts 0 7 (2.6%)
No. patients 7 (7%)
PPp
No. grafts 8 (3%)
No. patients 8 (8%)
GG, Good flow with IFI and good flow with TTFM; GP, good flow with IFI but
poor flow with TTFM; PG, poor flow with IFI but good flow with TTFM; PPt,
grafts with initial poor flow with IFI and TTFM that were subsequently
adequate; PPp, Grafts with persistent poor flow with both IFI and TTFM
that were revised.IFI and TTFM in 8 (3%) grafts in 8 (8%) patients, thus
c and Cardiovascular Surgery ● Volume 130, Number 2 317
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CSPprompting graft revision (category PPp). None of these
patients showed any electrocardiographic or significant he-
modynamic changes to indicate graft compromise. Re-
exploration of the anastomosis in these failed grafts showed
3 likely causes for poor flow (1 intimal flap, 1 thrombosis,
and 1 kink) but showed no definite cause in the remaining 5.
The functional status of the revised grafts was reassessed
with both IFI and TTFM in all cases but 1 (because of
equipment failure) and was confirmed to be acceptable
TABLE 3. Details of cases that demonstrated good flow wi
transit-time flowmetry (TTFM) and that were not revised
Patient
no.
Age
(y) Sex
No. diseased
vessels S
1 73 F 2 LITA-OM
2 58 M 3 LITA-OM
3 49 M 3 RA-PDA
LITA-O
4 62 M 3 Recycled
(proxim
5 65 M 2 RITA-LA
6 64 M 3 LITA-OM
7 73 F 2 LITA-LAD
8 58 M 3 LITA bet
LAD (s
D1 an
9 69 M 3 Proxima
LITA-L
10 75 M 2 LITA-D1
MGF, Mean graft flow; PI, pulsatility index; LITA, left internal thoracic arte
graft; OM, obtuse marginal coronary artery; LAD, left anterior descending c
artery; PDA, posterior descending coronary artery.
TABLE 4. Details of cases that demonstrated transient poor
flowmetry (TTFM) flow but that improved after pharmacolo
Patient
no.
Age
(y) Sex
No. diseased
vessels Suspected gr
1 75 M 3 LITA-LAD
2 74 F 3 Proximal limb of L
(RA-D1 from LIT
3 61 F 3 RITA-LAD (proxim
attached to LIT
4 53 M 2 RITA-LAD
5 50 M 3 LITA-IM
6 63 F 3 LITA-OM
7 69 M 3 SVG-PDA
MGF, Mean graft flow; PI, pulsatility index; LITA, left internal thoracic arte
graft; OM, obtuse marginal coronary artery; LAD, left anterior descending c
artery; PDA, posterior descending coronary artery; IM, intermediate artery.
318 The Journal of Thoracic and Cardiovascular Surgery ● Augu(Table 5). In these cases, the MGF increased significantly
from 2.0  1.2 mL/min to 12.9  9.3 mL/min (P  .005),
and there was a simultaneous decrease in PI values from
29.8  22.1 to 6.9  9.9 (P  .01).
Discussion
Verification of patency after most vascular procedures, such
as percutaneous coronary intervention, is standard practice.
However, although the rationale for routine intraoperative
traoperative fluorescence imaging (IFI) but poor flow with
cted graft
Good flow
seen on IFI
TTFM
MGF
(mL/min) PI
Yes 3 8.2
Yes 5 2.4
imal-end RA to Yes 3 5.4
A-D1
to LITA-LAD)
Yes 4 5.6
Yes 3 2.7
Yes 4 7.4
Yes 1 5.2
D1 and distal
ntial LITA to
tal LAD)
Yes 2 2.4
(sequential
nd D1)
Yes 5 8.4
Yes 4 2.6
ITA, right internal thoracic artery; RA, radial artery; SVG, saphenous vein
ry artery; D1, first diagonal branch of the left anterior descending coronary
aoperative fluorescence imaging (IFI) flow and transit-time
manipulation and did not require revision
Good flow on
repeat IFI
TTFM initial flow
value
TTFM subsequent
flow value
MGF
(mL/min) PI
MGF
(mL/min) PI
Yes 8 7.6 27 1.9
OM Yes 2 4.9 7 2.3
TA Yes 2 8.4 8 3.3
Yes 3 6.8 30 3
Yes 2 12 11 4.1
Yes 0 12 7 4.3
Yes 12 15.4 24 3
ITA, right internal thoracic artery; RA, radial artery; SVG, saphenous vein
ry artery; D1, first diagonal branch of the left anterior descending coronaryth in
uspe
(prox
M)
LIT
ally
D
ween
eque
d dis
l LITA
AD a
ry; R
oronaintr
gic
aft
ITA-
A)
al RI
A)
ry; R
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Passessment of CABG grafts is overwhelming, this fre-
quently does not occur in practice. Furthermore, although
several randomized controlled trials have compared the
clinical outcome of OPCABG and ONCABG,12,13 none has
evaluated intraoperative graft patency. This is somewhat
surprising, because OPCABG—especially when performed
with arterial grafts14—is often considered to be technically
more challenging.
Several techniques are available for intraoperative graft
patency assessment.15-20 We have previously reported the
value and simplicity of IFI in assessing graft patency,5,6 but
TTFM is currently the most commonly used technique.
Whereas IFI interpretation depends on immediate visual
feedback, interpretation of TTFM relies not only on MGF,
but also on flow waveform analysis and calculated deriva-
tives, such as PI. Although a high MGF and low PI value
provide good confirmation of graft patency, lower MGF and
higher PI values, in the absence of visual feedback, can be
difficult to interpret because there are no absolute values to
determine when grafts should be revised.
Using TTFM, D’Ancona and colleagues1 revised 37
(3.2%) of 1145 grafts in 33 (7.6%) of 409 OPCABG pa-
tients. They emphasized the reliance on correct analysis of
TTFM flow patterns to correct abnormalities and reported a
predominantly systolic flow in 34 of the 37 grafts, which
had altered to a diastolic pattern after revision. Generally,
they accepted a PI less than 5 and stated that MGF alone is
not a good indicator of graft patency. However, definitive
values were not described to determine graft patency, espe-
cially in low flow situations. In our study, although we
found that flow patterns are useful to confirm graft patency
in conjunction with adequate MGF and low PI values, the
systolic and diastolic profiles of the flow waveform are not
TABLE 5. Details of the cases that demonstrated persisten
and transit-time flowmetry (TTFM) and that were revised
Patient
no.
Age
(y) Sex
No. diseased
vessels Culprit anastomos
1 68 M 3 LITA-OM
2 72 M 3 RA-D1 (RA proxim
end to LITA-LA
3 69 F 2 LITA-OM
4 69 M 3 SVG-PDA
5 50 M 3 RITA-LAD
6 64 F 3 SVG-OM
7 51 M 2 LITA-LAD
8 73 F 2 RITA-LAD
MGF, Mean graft flow; PI, pulsatility index; LITA, left internal thoracic arte
graft; OM, obtuse marginal coronary artery; LAD, left anterior descending c
artery; PDA, posterior descending coronary artery.always evident in low-flow situations, thus compounding
The Journal of Thoracithe ambiguity in terms of interpreting PI in the setting of a
low MGF.
In practice, in most situations, interpretation of TTFM is
straightforward, and we found good correlation between IFI
and TTFM for most grafts. Indeed, for the categories GG
and PP (both transient and persistent), which accounted for
256 (96%) of 266 grafts, similar information was provided
with both techniques. Whereas there was no incidence of
PG (ie, poor flow with IFI but good flow with TTFM), there
were 10 cases of GP (ie, good flow with IFI but poor flow
with TTFM). Although there were only 10 grafts in this
category (3.8% of all grafts), because these occurred in
different patients, this could have resulted in unnecessary
graft revision in 10% of patients.
Of 15 grafts in category PP, 7 were subsequently clas-
sified as PPt, thus indicating that the initial poor graft flow
was transient and improved after a period of increased
MAP. As shown in Table 4, PPt grafts subsequently dem-
onstrated improved mean flows and a lower PI, and these
grafts were therefore not revised. It is of particular note that
the appearance of fluorescence in these grafts was initially
only moderately delayed to between 15 to 25 seconds.
This phenomenon of transient poor flow may be ex-
plained by several mechanisms. Luxation and rotation of the
heart with the patient in the Trendelenburg position
achieves a suitable position for performing the anastomosis
and imaging the graft. Restoring the heart to the normal
anatomic position usually increases the MAP and possibly
results in increased graft flow. Alternatively, arterial graft
spasm after immediate handling of the graft may resolve
spontaneously with an increased MAP. In some situations,
the same effect was achieved by a small dose of
r flow with both intraoperative fluorescence imaging (IFI)
Postrevision good
flow seen on IFI
Prerevision TTFM Postrevision TTFM
MGF
(mL/min) PI
MGF
(mL/min) PI
Yes 3 55 12 3
Yes 0 9.8 2 3.2
Yes 3 4.4 11 1.1
Yes 3 33 9 29
Yes 1 47 32 3.2
Yes 2 58 — —
Yes 1 26 9 7.1
Yes 3 4.7 15 1.6
ITA, right internal thoracic artery; RA, radial artery; SVG, saphenous vein
ry artery; D1, first diagonal branch of the left anterior descending coronaryt poo
is
al
D)
ry; R
oronavasoconstrictors.
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CSPHowever, category PP contained a further 8 grafts (3%)
in 8 (8%) patients classified as PPp, indicating persistent
poor flow with both TTFM and IFI, even after the heart was
restored to its normal position and MAP was increased for
10 to 20 minutes. These grafts were therefore revised (and
there were no deaths or perioperative myocardial infarctions
in this group). However, in only 3 cases was a definite
reason found for poor flow, and even after revision, as
shown in Table 5, most showed only a moderate increase in
flow.
Likely mechanisms for persistently poor flow include
1. Competitive flow from the native coronary vessel
with a less-than-critical stenosis. The use of a prox-
imal snare can confirm this likelihood, because it
results in an increase in graft flow.
2. Poor distal runoff either because of severe distal
disease in the grafted coronary vessel or because of a
noncompliant distal coronary vascular bed (similar to
the no-reflow angiographic phenomenon sometimes
seen on angiography after patency is restored in an
occluded vessel).
Although it is not our practice to perform routine post-
operative angiograms, long-term angiographic patency data
would be invaluable in determining the natural history of
these grafts.
Limitations
There are 2 limitations to our study. Interpretation of good
and poor flow with both techniques is semisubjective, even
though it is based on considerable clinical experience, and
the lack of angiographic follow-up precludes understanding
the fate of the grafts with initial or persistent poor flow.
Conclusion
In most grafts, IFI and TTFM correlate well with each other
and provide adequate confirmation of graft patency. How-
ever, in a small proportion of grafts (but in up to 10% of
patients), TTFM alone might result in unnecessary graft
revision.
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